Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
Fort Meade Meddac Lab Chemistry is a federal award for W40m Rhco Atlantic held by Ortho-Clinical Diagnostics, Inc. Estimated value $3.8M ($2.5M obligated). Current period of performance ends Mar 31, 2025. Last award drew 1 bidder. Place of performance: FORT GEORGE G MEADE MD. Related solicitation W91YTZ19R0090.
Fort meade meddac lab chemistry. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Mar 31, 2025 (569 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W91YTZ19F0196? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W91YTZ19F0196?
W91YTZ19F0196 (Fort meade meddac lab chemistry) is a W40m Rhco Atlantic award with a potential value of $3.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W91YTZ-19-F-0196?
W91YTZ-19-F-0196 is the dashed form of PIID W91YTZ19F0196 (Fort meade meddac lab chemistry), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W91YTZ19F0196?
W40m Rhco Atlantic awarded W91YTZ19F0196 to Ortho-Clinical Diagnostics, Inc (potential $3.8M).
Who is the incumbent on W91YTZ19F0196?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2025.
When does Ortho-Clinical Diagnostics, Inc’s W91YTZ19F0196 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 31, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W91YTZ19F0196? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.